SPH Preliminary sales revenue data for June 2026

Sofia, Bulgaria, July 20, 2026 – “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) pursuant to the requirements of art. 100t of the Law on Public Offering of Securities (LPOS), announces that for June 2026 the Company reported an increase in sales of 3% compared to the same month of the previous year, including 5% decrease in domestic sales and 8% increase in export sales.
For the period from the beginning of 2026, the Company achieved sales growth of 33%, including a 6% decrease in domestic sales and sales growth of 33% in export.